Dr. Andrew J. Holcomb, MD

Dr. Holcomb practices at Nebraska Methodist Hospital in Omaha, Nebraska.

Dr. Holcomb's NPI, 1205246147, was assigned on April 30, 2014. Dr. Holcomb graduated from Eastern Virginia Medical School in 2014. Dr. Holcomb holds Massachusetts license 249277.

Dr. Holcomb's primary practice is Nebraska Methodist Hospital, at 8303 Dodge St, Omaha, NE 68114 in Douglas County. The practice phone is (402) 354-4000.

Dr. Holcomb's primary practice is Nebraska Methodist Hospital in Omaha, Nebraska. Dr. Holcomb is also affiliated with Methodist Hospital. The medical group on file is Nebraska Methodist Hospital. Dmand AI also links Dr. Holcomb to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Holcomb practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Holcomb's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Holcomb is licensed in Massachusetts.

CMS data shows 703 Medicare services from Dr. Holcomb across 9 procedure codes in 2024, for 262 Medicare patients. Medicare paid $60,665 for them.

CMS counts 262 Medicare patients who saw Dr. Holcomb in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Holcomb's median patient age at 63, with 52% women.

In 2024, Dr. Holcomb wrote 240 Medicare Part D claims for 63 patients. 89% of them were for generic drugs. CMS names the drug for 134 of them, across 3 drugs with 11 or more claims each, at $1,020 in total drug cost. In 2023, CMS named 64 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 52 out of 100 for Dr. Holcomb for performance year 2024, reported individually. Dr. Holcomb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Holcomb as offering telehealth. CMS counts 26 procedures of melanoma (skin cancer) excision by Dr. Holcomb, more than 78% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Holcomb, published from 2018 to 2025. 2021 was the busiest year, with 7. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Mouth Neoplasms. Dr. Holcomb has published most often in Head Neck. Dr. Holcomb's most frequent co-authors are Jeremy Richmon, MD, Kiran Kakarala, MD and Daniel G. Deschler, MD.

CMS Open Payments shows 28 general payments to Dr. Holcomb from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Stryker Corporation paid the most, $661.

Dr. Holcomb graduated from Eastern Virginia Medical School in 2014.